OncBlog

OncBlog

This is the collection of OncBlog posts.

Hematology/Oncology Drug Approvals for 2019

In order to be approved by the U.S. Food and Drug Association (FDA), potential new cancer therapies and drugs must go through clinical trials. Products awaiting approval can be anywhere from brand-new therapies to small additions to already-existing drugs. Public…

Read Full

An Overview of Clinical Trials

While clinical trials are extremely important to study all types of medicine, clinical trials for oncology are particularly important as they help researchers advance new treatment options. During a clinical trial, participants volunteer to try new drugs or treatments so…

Read Full

What Is Value-Based Healthcare?

As an oncology provider, the term value-based healthcare is often used in discussions regarding payment and patient care. But what exactly does value-based care mean? Let’s unpack some of the key pieces of this framework.   Quality Versus Quantity Value-based…

Read Full

Patient-Centered Care: Treating the Patient, Not Just the Disease

The concept of patient-centered care – treating the entire patient, not just the disease the patient is facing – should not seem so far fetched. But for many in today’s healthcare landscape, even the idea of working this way requires…

Read Full

Physician Practice Management Challenges

Physician Practice Management Challenges If you are managing an oncology practice, you know that there are many challenges that extend beyond your medical school training. In addition to providing care for your patients, you also have the challenge of running…

Read Full

Verdi Oncology, Inc. Partners with Detroit Physician to Open New Practice Location

Dr. Tarik Hadid Provides Comprehensive and Personalized Oncology Care in Detroit and Warren, MI NASHVILLE, Tenn., Dec. 19, 2018 /PRNewswire/ — Verdi Oncology, Inc., an oncology practice and clinical research management company, announced today it has partnered with Dr. Tarik Hadid to open Verdi…

Read Full

Verdi Oncology: 2018 Overview

It was a significant year for Verdi Oncology. We opened for business in the spring of 2018 for the expressed purpose of providing value-based, patient-centric oncology care to new markets. We approach this strategy in one of two ways: Partnering…

Read Full

EBITDA – The Oncology Valuation Series

EBITDAWhat is it, and why does it matter? The Oncology Valuation SeriesNovember 21, 2018 Wes ChapmanPresident & CEO of Verdi Oncology, Inc. My job puts me in front of physician owners of medical oncology practices at least 4-5 times per month,…

Read Full

240% Growth in Oncology Drug Approvals in 2017; Good News for Cancer Patients

240% Growth in Oncology Drug Approvals in 2017 Good News for Cancer Patients Wes Chapman January 2, 2018 Introduction Advances in medical oncology depend on successful drug development – and that means successful clinical trials, leading to approval by the…

Read Full

MIPS for Medical Oncology Practices – Strategic Considerations

MIPS/MACRA 2018 Strategic Considerations for Medical Oncology Practices Implications of a Zero Sum Game Wes Chapman December 2017 A Doomsday Solution to a Zero Sum Game   Strategic Situational Analysis   MACRA/MIPS (MIPS) will become the operational standard in 2018…

Read Full